Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Christy J. Wilson

Christy J. Wilson

Sr. Director, Pharma and Biotech Segment

Connect with Christy J. Wilson on LinkedIn
Follow Christy J. Wilson on Twitter
Website:

About the author:

Christy brings more than 20 years of global life science and healthcare industry experience to her role as Senior Director, Segment Marketing for the biopharmaceutical industry segment at Elsevier. In this capacity she is focused on understanding biopharmaceutical R&D challenges and the implications for Elsevier in terms of market led growth opportunities that will improve productivity and success for industry executives and their teams. She also plays a key role in increasing Elsevier’s share-of-voice and market share through strategic go-to-market planning and execution.

Prior to joining Elsevier, Christy held senior marketing and business development roles in Wolters Kluwer’s Pharma Solutions Business Unit where she was responsible for product management and marketing of the Adis portfolio of drug focused journals and newsletters, pipeline and clinical trials intelligence tools, and pharmacovigilance solutions. During her Wolters Kluwer tenure, Christy also worked in the group’s Healthcare Analytics business, a business that provided powerful data, applications, analytics, and consulting to help companies gain deep insight into the pharmaceutical market.

Christy resides in the greater New York City area and holds an MBA in International Business from DePaul University (Chicago) and a BS in Marketing, from Miami University (Ohio).


Posts by Christy J. Wilson

Experts Gather for a Pair of Pharma & Biotech Conferences

Posted on October 22nd, 2018 in Pharma R&D

From October 29-30, London will be the site of two important events for the pharma and biotech industries, the 2nd Medicinal Chemistry Summit: Europe and the 2nd Global Pharma R&D Informatics & AI Congress. Presented by Global Engage, the conferences will be co-located at the Radisson Blu Edwardian Heathrow, opening up the opportunity for industry professionals to sample what each has to offer.  Continue reading “Experts Gather for a Pair of Pharma & Biotech Conferences” »

Are Drug-Drug Interactions Today’s Biggest Health Threat?

Posted on October 16th, 2018 in Pharma R&D

The use of prescription medicines is sharply on the rise. Over the past decade, the number of adults taking over-the-counter medicines has sunk, while the number of prescription drug users has increased by more than 30 percent. Continue reading “Are Drug-Drug Interactions Today’s Biggest Health Threat?” »

Human Cells + Tech = Accelerated Drug Development and Treatment

Posted on October 16th, 2018 in Pharma R&D

Some scientific advancements can be both awe-inspiring and just a little creepy at the same time. In the world of pharma and medicine, this applies to some newer approaches that are melding living cells with high-tech to do some wonderful things. Two such advances, which made the short list for BiopharmaTrend.com’s top trends in pharmaceutical research for 2018, are organs-on-chips and bioprinting. Continue reading “Human Cells + Tech = Accelerated Drug Development and Treatment” »

How Drug Repurposing Is Revitalizing the Pharma Industry

Posted on October 16th, 2018 in Pharma R&D

The average expense of bringing a new drug to market has increased by more than 200 percent since the 1990s, with development costs regularly running into the billions. As pharma revenues continue to sink below the costs of creating commercially viable drugs, a growing number of developers are exploring a different approach: seeking out additional monetizable uses for drugs to which they already own intellectual property rights. Continue reading “How Drug Repurposing Is Revitalizing the Pharma Industry” »

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 11